STR Webinar: Understanding U.S. Customs Origin Determinations in the Biopharma and Life Sciences Industry
Biopharma and life sciences companies face unique challenges when determining the country of origin for imports for research and development, clinical, and commercial cross-border transactions. These origin decisions must comply with U.S. customs laws for origin declaration for duty payments and origin marking, while also considering a myriad of other labeling concerns. This webinar provides an overview of basic U.S. customs law origin principles and highlights specific areas for review relevant to the industry.
Key Topics
Legal framework and importance of origin determination for the biopharma and life sciences industry
Substantial transformation for biopharma and life sciences
Small case studies of key U.S. Customs Rulings
Using origin as part of a duty reduction strategy
Risks with origin labeling and Partner Government Agencies
